Role of Matrix Metalloproteinase -9 (Mmp -9) Concentration in The Pathogenesis of Preeclampsia
DOI:
https://doi.org/10.59675/Keywords:
Preeclampsia, Term, Pre-term, Metalloproteinase-9.Abstract
Background: Preeclampsia is a syndrome related to pregnancy and represented the second common maternal and infant death causes. Metalloproteinase is involved in vascular growth of placenta, and it has been shown to have a role in preeclampsia pathogenesis.
Aim of study: The evaluation of metalloproteinase role in prediction of pre-eclampsia in pregnancy.
Patients and methods: This is a case control study conducted at Obstetric & Gynecological Department of Al-Daquq general hospital in Kirkuk during the period from 1st of March to end of November 2017.A sample of 50 preeclamptic pregnant women, 25 preeclamptic pregnant females of gestational age of (< 37 weeks) and 25 preeclamptic pregnant women with gestational age of (more than 37 weeks) were included in the study. A sample of 50 healthy controls, 25 healthy pregnant women with gestational age of (<37 weeks) and 25 healthy pregnant females with gestational age of (more than 37 weeks).
Results: In contrast to preterm controls, there was a highly important correlation between lower mean Metalloproteinase-9 and pregnant preterm women with preeclampsia (p<0.001). In contrast to term controls, a highly significant correlation was observed between lower mean Metalloproteinase-9 and term pregnant women with PE (p<0.001). In pre-eclampsia prediction, Metalloproteinase-9 levels of 26.2 for pre-term and 34.4 for term were cut off.
Conclusions: The matrix metalloproteinase 9 is a nonspecific predictor of preeclampsia for term and preterm pregnant women but with higher accuracy for preterm pregnant women.
References
Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams Obstetrics. 24th ed. McGraw-Hill; 2014. p.m. 730.
Edmonds DK. Normal and abnormal development of the genital tract. In: Edmonds DK, editor. Dewhurst's Textbook of Obstetrics & Gynaecology. 8th ed. Oxford: Wiley-Blackwell; 2012. p. 421-34.
Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH. Ten years of confidential inquiries into maternal deaths in France, 1998–2007. Obstet Gynecol. 2013;122(4):752-60.
Konar H. DC Dutta's Textbook of Obstetrics. 7th ed. New Delhi: Jaypee Brothers Medical Publishers; 2014. p. 219.
Goodwin TM, Montoro MN, Muderspach L, Paulson R, Roy S, editors. Management of Common Problems in Obstetrics and Gynecology. 5th ed. Oxford: Wiley-Blackwell; 2010.
Rizvi M, Singh RB, Tripathi R, Immaculate S. New approach to treat an old problem: Mannitol for post-dural puncture headache! Indian J Anaesth. 2015;59(4):260-1.
Jeha D, Usta I, Ghulmiyyah L, Nassar A. A review of the risks and consequences of adolescent pregnancy. J Neonatal Perinatal Med. 2015;8(1):1-8.
Kelishadi R, Poursafa P. A review on the genetic, environmental, and lifestyle aspects of the early-life origins of cardiovascular disease. Curr Probl Pediatr Adolesc Health Care. 2014;44(3):54-72.
Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by pre-eclampsia and preterm labor. Reprod Sci. 2011;18(1):46-57.
Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy. 2012; 2012:1-19.
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-44.
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.
Baker PN, Kenny L, editors. Obstetrics by Ten Teachers. 19th ed. CRC Press; 2011. p. 122.
Wikström AK, Gunnarsdóttir J, Cnattingius S. The paternal role in pre-eclampsia and giving birth to a small for gestational age infant: a population-based cohort study. BMJ Open. 2012;2(4): e001178.
Müller-Deile J, Schiffer M. Preeclampsia from a renal point of view: insights into disease models, biomarkers, and therapy. World J Nephrol. 2014;3(4):169-81.
Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf). 2013;208(3):224-33.
Semenovska Z, Erogul M. Pregnancy, preeclampsia: emergency medicine. Obstet Gynaecol. 2010;6.
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: WHO; 2013.
Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858-67.
Gibbs RS, Karlyn BY, Haney AF, Nygaard I. Danforth's Obstetrics and Gynecology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
Laskowska M. Altered maternal serum matrix metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in severe early-and late-onset preeclampsia. Biomed Res Int. 2017; 2017:1-9.
Waugh JJ, Smith MC. Hypertensive disorders. In: Edmonds DK, editor. Dewhurst's Textbook of Obstetrics & Gynaecology. 8th ed. Oxford: Wiley-Blackwell; 2011. p. 101-22.
Worley KC, Hnat MD, Cunningham FG. Advanced extrauterine pregnancy: diagnostic and therapeutic challenges. Am J Obstet Gynecol. 2008;198(3): 297.e1-297.e7.
Redman CW, Sargent IL, Taylor RN. Immunology of abnormal pregnancy and preeclampsia. In: Taylor RN, Roberts JM, Cunningham FG, editors. Chesley's Hypertensive Disorders in Pregnancy. 4th ed. Amsterdam: Academic Press; 2014.
Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007;178(9):5949-56.
LaMarca B, Parrish M, Ray LF. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension. 2009;54(4):905-11.
LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008;52(6):1168-72.
Karumanchi A, Rana S, Taylor RN. Angiogenesis and pre-eclampsia. In: Taylor RN, Roberts JM, Cunningham FG, editors. Chesley's Hypertensive Disorders in Pregnancy. 4th ed. Amsterdam: Academic Press; 2014.
Haggerty CL, Seifert ME, Tang G. Second trimester anti-angiogenic proteins and pre-eclampsia. Pregnancy Hypertens. 2012;2(2):158.
Lalu MM, Xu H, Davidge ST. Matrix metalloproteinases: control of vascular function and their potential role in preeclampsia. Front Biosci. 2007; 12:2484-93.
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52-67.
Anacker J. Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol Hum Reprod. 2011;17(10):637-52.
Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci USA. 2013;110(27):11109-14.
Cohen M, Meisser A, Bischof P. Metalloproteinases and human placental invasiveness. Placenta. 2006;27(8):783-93.
Rahimi Z, Rahimi Z, Shahsavandi MO, Bidoki K, Rezaei M. MMP-9 (-1562 C: T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia. Biomarkers Med. 2013;7(1):93-98.
Levine RJ, Maynard SE, Qian C. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-83.
Gupta M, Chari S. Assessment of matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in pre-eclampsia. Int J Sci Study. 2016;3(11):70-3.
Moon SK, Cha BY, Kim CH. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappa B and AP-1: involvement of the ras dependent pathway. J Cell Physiol. 2004;198(3):417-27.
Cohen M, Meisser A, Haenggeli L, Bischof P. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod. 2006;12(4):225-32.
Feng G, Wang J, Zhang J. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in serum and placenta of patients with pre-eclampsia. Int J Gynaecol Obstet. 2015;93(2):144-5.
Wang Y, Gu Y, Philibert L, Lucas MJ. Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro. Placenta. 2001;22(6):560-5.
Akins ML, Luby-Phelps K, Bank RA, Mahendroo M. Cervical softening during pregnancy: regulated changes in collagen cross-linking and composition of matricellular proteins in the mouse. Biol Reprod. 2011;84(5):1053-62.
Higgins JR, Walshe JJ, Darling MR, Norris L, Bonnar J. Neutrophil activation in pre-eclampsia. Br J Obstet Gynaecol. 1998;105(6):558-9.
Shiozaki A, Nakashima A, Yoneda S, Sakai M, Nishio J, Hidaka T, et al. Impaired IFN-gamma-induced tryptophan catabolism is associated with preeclampsia. Med Sci Monit. 2011;17(2):CR48-54.
Romero R, Kusanovic JP, Chaiworapongsa T, Hassan SS. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):313-27.
Lyall F, Bulmer JN, Duffie E, Cousins F, Theriault A, Robson SC. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol. 2001;158(5):1713-21.
Brosens I, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972; 1:177-91.
Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta. 1983;4(4):397-413.
Lyall F. The human placental bed revisited. Placenta. 2002;23(8-9):555-62.
Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193-201.
Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age infants. Br J Obstet Gynaecol. 1986;93(10):1049-59.
Staff AC, Johnsen GM, Dechend R, Redman CW. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol. 2014;101-102:120-6.
Platt JS, Hunt JS. Interferon-gamma gene expression in cycling and pregnant uterus: temporal aspects and cellular localization. J Leukoc Biol. 1998;64(1):66-74.
Kaitu'u-Lino TJ, Moravec R, Bromfield A, Tong S. Maternal platelet toll-like receptor 7 is downregulated in pregnancies complicated by pre-eclampsia. Hypertens Pregnancy. 2014;33(3):313-20.
Mariona FG, Plouffe L Jr. Interferons and the human placenta. Obstet Gynecol Surv. 1991;46(4):239-45.
Whitten AE, Kingston D, Kenna GA, Makris A. Effects of preeclampsia on maternal endothelium. Curr Hypertens Rep. 2013;15(6):533-41.
Wolf M, Sauk J, Shah A, Jimenez-Kimble R, Ecker JL, Thadhani R. Preeclampsia and future cardiovascular disease in women: how substantial is the association? Hypertension. 2004;43(6):137-9.
Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Tanbo T, Abyholm T, et al. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in preeclampsia, normotensive pregnancies, and nonpregnant women. Am J Obstet Gynecol. 2009;201(4): 396.e1-396.e8.
Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain AJ, Tamez H, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007;50(1):137-42.
Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in pre-eclamptic patients. Am J Obstet Gynecol. 2012;206(1):58. e1-58. e8.
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-58.
Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992-1005.
Sugulle M, Dechend R, Herse F, Weedon-Fekjær SM, Johnsen GM, Brosnihan KB, et al. Circulating and uteroplacental expression of soluble endoglin, activin A, and inhibin A in preeclampsia. Eur J Endocrinol. 2009;160(1):33-9.
Lynch AM, Murphy JR, Byers T, Gibbs RS, Neville MC, Giclas PC, et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol. 2008;198(4): 385.e1-385.e9.
Lynch AM, Murphy JR, Gibbs RS, Levine RJ, Giclas PC, Salmon JE, et al. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with preeclampsia. BJOG. 2010;117(4):456-62.
Luo Q, Xu J, Tong Y, Yang F, Han J, Yang X, et al. The influence of decorin on the biological behavior of trophoblasts and endothelial cells. PLoS One. 2013;8(11): e79651.
Singnoi W, Numprasert W, Sinawat S, Viprakasit V. Hemolytic uremic syndrome associated with pneumococcal infection: case reports and literature review. Southeast Asian J Trop Med Public Health. 2011;42(4):1020-6.
Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193-201.
Staff AC. The two-stage placental model of pre-eclampsia: an update. J Reprod Immunol. 2009;82(1):1-10.
Rusterholz C, Hahn S, Holzgreve W. MicroRNAs: markers for the preeclampsia? Hypertens Pregnancy. 2011;30(2):643-50.
Farina A, Sekizawa A, Rizzo N, Concu M, Purwosunu Y, Banzola I, et al. Cell-free RNA (cfRNA) in maternal blood: a new tool to study the physiology of pregnancy. Clin Chem. 2006;52(9):1865-7.
Calda P, Cuckle H. Prenatal screening for preeclampsia. Curr Opin Obstet Gynecol. 2018;30(2):115-22.
Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension. 2000;35(1):367-72.
Young BC, Levine RJ, Karumanchi SA. Pathogenesis of pre-eclampsia. Annu Rev Pathol. 2010; 5:173-92.
Roberts JM, Hubel CA. The two-stage model of preeclampsia: variations on the theme. Placenta. 2009;30 Suppl A: S32-7.
Myatt L. Role of placenta in pre-eclampsia. Endocrine. 2002;19(1):103-11.
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-44.
Sibai BM, Caritis S, Hauth J. What we have learned about pre-eclampsia. Semin Perinatol. 2003;27(3):239-46.
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med. 2004;350(7):672-83.
Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young BK, editor. Am J Obstet Gynecol. 2004;190(6):1541-7.
Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia–novel aspects for atherosclerosis and future cardiovascular health. Hypertension. 2010;56(6):1026-34.
Holthe MR, Staff AC, Berge L, Fagerhol MK, Lyberg T, Eik-Nes SH, et al. Calprotectin plasma level is elevated in preeclampsia. Acta Obstet Gynecol Scand. 2005;84(2):151-4.
Ma Y, Ye W, Zhang J, Ruan CC, Gao PJ. Immune imbalance is associated with the development of preeclampsia. Medicine (Baltimore). 2020;99(17): e20077.
Cipolla MJ. Cerebrovascular function in pregnancy and eclampsia. Hypertension. 2007;50(1):14-24.
Berg CJ, Harper MA, Atkinson SM, Bell EA, Brown HL, Hage ML, et al. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol. 2005;106(6):1228-34.
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.
Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993;341(8858):1447-51.
Wallace AE, Host AJ, Whitley GS, Cartwright JE. Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies with high uterine artery resistance. J Pathol. 2013;229(3):401-11.
Marazzi E, Galgani R, Grossi E, Rossi M, Mosconi P. Preeclampsia and human evolution: a model-based approach. PLoS One. 2018;13(8): e0203600.
Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389-93.
Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002;287(24):3183-6.
Min JW, Moon JY, Kim SY, Kim YH, Moon JH, Jang HJ, et al. Identification of anti-angiogenic genes as diagnostic biomarkers for preeclampsia. BMC Med Genomics. 2018;11(1):102.
Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Assche A. A study of placental bed spiral arteries and trophoblastic invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101(8):669-74.
Huppertz B. Placental origins of pre-eclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970-5.
Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499-506.
Moldenhauer JS, Stanek J, Warshak CR, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol. 2003;189(4):1173-7.
De Wolf F, Brosens I, Robertson WB. The human placental bed: electron microscopic study of trophoblastic invasion of spiral arteries. Am J Obstet Gynecol. 1979;134(4):437-43.
ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133(1):1-25.
Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Preeclampsia part 1: Current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466-80.
von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22(2):143-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Academic International Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
